| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Health Care | 40 | 2026 | 380 | 6.460 |
Why?
|
| Manitoba | 50 | 2025 | 53 | 3.470 |
Why?
|
| Canada | 48 | 2026 | 163 | 3.140 |
Why?
|
| Family Practice | 11 | 2026 | 60 | 2.540 |
Why?
|
| Mental Disorders | 10 | 2025 | 392 | 1.890 |
Why?
|
| Physicians, Family | 10 | 2026 | 29 | 1.850 |
Why?
|
| Health Services, Indigenous | 3 | 2021 | 33 | 1.800 |
Why?
|
| Healthcare Disparities | 8 | 2025 | 590 | 1.750 |
Why?
|
| Humans | 155 | 2026 | 43102 | 1.680 |
Why?
|
| Gonorrhea | 6 | 2011 | 24 | 1.630 |
Why?
|
| Chronic Disease | 7 | 2021 | 549 | 1.610 |
Why?
|
| Adult | 71 | 2026 | 13872 | 1.300 |
Why?
|
| Male | 93 | 2026 | 23409 | 1.290 |
Why?
|
| Income | 6 | 2023 | 160 | 1.280 |
Why?
|
| Indians, North American | 3 | 2019 | 192 | 1.270 |
Why?
|
| Middle Aged | 66 | 2026 | 12222 | 1.270 |
Why?
|
| Female | 93 | 2026 | 24698 | 1.250 |
Why?
|
| Aged | 51 | 2025 | 8214 | 1.250 |
Why?
|
| Mental Health Services | 5 | 2025 | 141 | 1.250 |
Why?
|
| Research Design | 11 | 2025 | 385 | 1.170 |
Why?
|
| Poverty | 5 | 2026 | 400 | 1.140 |
Why?
|
| Retrospective Studies | 32 | 2026 | 2544 | 1.100 |
Why?
|
| Electronic Health Records | 5 | 2025 | 108 | 1.090 |
Why?
|
| Hospitalization | 9 | 2025 | 485 | 1.090 |
Why?
|
| Population Surveillance | 10 | 2021 | 246 | 1.060 |
Why?
|
| Reimbursement, Incentive | 2 | 2018 | 12 | 1.030 |
Why?
|
| Health Services Accessibility | 10 | 2025 | 706 | 1.020 |
Why?
|
| Analgesics, Opioid | 3 | 2025 | 252 | 0.990 |
Why?
|
| Leptospirosis | 5 | 2011 | 31 | 0.960 |
Why?
|
| Young Adult | 33 | 2025 | 5080 | 0.950 |
Why?
|
| Quality of Health Care | 5 | 2022 | 161 | 0.930 |
Why?
|
| Adolescent | 35 | 2025 | 6081 | 0.920 |
Why?
|
| Cardiovascular Diseases | 8 | 2025 | 749 | 0.910 |
Why?
|
| Patient Care Team | 6 | 2026 | 60 | 0.890 |
Why?
|
| Child | 23 | 2025 | 3443 | 0.870 |
Why?
|
| Internship and Residency | 3 | 2026 | 146 | 0.870 |
Why?
|
| Ambulatory Care | 3 | 2021 | 81 | 0.860 |
Why?
|
| Ontario | 16 | 2026 | 39 | 0.810 |
Why?
|
| Aged, 80 and over | 18 | 2025 | 2853 | 0.800 |
Why?
|
| Child, Preschool | 19 | 2025 | 1546 | 0.790 |
Why?
|
| Infant | 16 | 2025 | 1175 | 0.770 |
Why?
|
| Vaccination | 5 | 2025 | 355 | 0.750 |
Why?
|
| Pregnancy Outcome | 2 | 2025 | 102 | 0.740 |
Why?
|
| Prescriptions | 1 | 2022 | 19 | 0.740 |
Why?
|
| Bioterrorism | 3 | 2006 | 20 | 0.740 |
Why?
|
| Prenatal Care | 2 | 2025 | 93 | 0.730 |
Why?
|
| Community Health Services | 4 | 2019 | 206 | 0.730 |
Why?
|
| Cross-Sectional Studies | 20 | 2025 | 3156 | 0.700 |
Why?
|
| Psychiatry | 4 | 2025 | 36 | 0.700 |
Why?
|
| Delivery of Health Care | 8 | 2024 | 310 | 0.690 |
Why?
|
| Health Status Indicators | 1 | 2021 | 90 | 0.690 |
Why?
|
| Hospitals | 3 | 2023 | 117 | 0.680 |
Why?
|
| Hawaii | 20 | 2025 | 2011 | 0.680 |
Why?
|
| Review Literature as Topic | 2 | 2017 | 9 | 0.670 |
Why?
|
| Radiosurgery | 3 | 2021 | 56 | 0.670 |
Why?
|
| Health Policy | 3 | 2017 | 184 | 0.650 |
Why?
|
| Cohort Studies | 12 | 2026 | 1759 | 0.630 |
Why?
|
| Chlamydia Infections | 3 | 2009 | 200 | 0.630 |
Why?
|
| Leptospira | 4 | 2011 | 27 | 0.620 |
Why?
|
| Attitude of Health Personnel | 8 | 2020 | 231 | 0.620 |
Why?
|
| Clinical Competence | 4 | 2026 | 156 | 0.610 |
Why?
|
| Needs Assessment | 5 | 2025 | 178 | 0.610 |
Why?
|
| Infant, Newborn | 9 | 2025 | 972 | 0.600 |
Why?
|
| Attitude to Health | 2 | 2021 | 338 | 0.590 |
Why?
|
| Prevalence | 12 | 2025 | 1612 | 0.570 |
Why?
|
| Physicians | 5 | 2015 | 188 | 0.570 |
Why?
|
| Health Promotion | 5 | 2023 | 704 | 0.560 |
Why?
|
| Fractures, Comminuted | 1 | 2018 | 1 | 0.560 |
Why?
|
| Wrist Joint | 1 | 2018 | 3 | 0.560 |
Why?
|
| Radius Fractures | 1 | 2018 | 4 | 0.560 |
Why?
|
| Radiography | 1 | 2018 | 71 | 0.550 |
Why?
|
| Comorbidity | 7 | 2025 | 737 | 0.550 |
Why?
|
| Publications | 1 | 2017 | 10 | 0.550 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 49 | 0.550 |
Why?
|
| Vaccines | 3 | 2023 | 65 | 0.540 |
Why?
|
| Osteoporosis | 1 | 2018 | 45 | 0.540 |
Why?
|
| Holistic Health | 1 | 2017 | 13 | 0.530 |
Why?
|
| Forms and Records Control | 1 | 2017 | 6 | 0.530 |
Why?
|
| Pediatrics | 2 | 2021 | 70 | 0.520 |
Why?
|
| British Columbia | 11 | 2025 | 20 | 0.520 |
Why?
|
| Qualitative Research | 8 | 2025 | 574 | 0.510 |
Why?
|
| Influenza, Human | 2 | 2013 | 92 | 0.470 |
Why?
|
| Nurse Practitioners | 3 | 2025 | 24 | 0.460 |
Why?
|
| Cause of Death | 3 | 2020 | 186 | 0.460 |
Why?
|
| Disaster Planning | 2 | 2006 | 62 | 0.460 |
Why?
|
| Referral and Consultation | 2 | 2014 | 142 | 0.460 |
Why?
|
| Journal Impact Factor | 2 | 2025 | 3 | 0.450 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2011 | 16 | 0.450 |
Why?
|
| Specialization | 1 | 2014 | 26 | 0.440 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2012 | 90 | 0.430 |
Why?
|
| Heart Failure | 6 | 2025 | 302 | 0.430 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2016 | 174 | 0.420 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 539 | 0.420 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 2 | 0.420 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 223 | 0.410 |
Why?
|
| Coffee | 1 | 2013 | 20 | 0.410 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 24 | 0.410 |
Why?
|
| Hypospadias | 2 | 2025 | 4 | 0.400 |
Why?
|
| Socioeconomic Factors | 10 | 2022 | 1234 | 0.400 |
Why?
|
| Preventive Health Services | 2 | 2023 | 66 | 0.400 |
Why?
|
| Health Care Surveys | 5 | 2017 | 152 | 0.400 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2025 | 34 | 0.390 |
Why?
|
| Carcinoma | 1 | 2014 | 108 | 0.390 |
Why?
|
| Health Status Disparities | 5 | 2025 | 719 | 0.380 |
Why?
|
| Mental Health | 2 | 2021 | 385 | 0.380 |
Why?
|
| Health Care Reform | 3 | 2025 | 36 | 0.380 |
Why?
|
| Myocardial Ischemia | 3 | 2019 | 83 | 0.380 |
Why?
|
| Patient-Centered Care | 4 | 2022 | 75 | 0.370 |
Why?
|
| Health Services Research | 3 | 2018 | 161 | 0.370 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 184 | 0.370 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 167 | 0.360 |
Why?
|
| Azithromycin | 1 | 2011 | 7 | 0.360 |
Why?
|
| Pneumonia, Viral | 1 | 2013 | 88 | 0.360 |
Why?
|
| Incidence | 10 | 2025 | 1078 | 0.350 |
Why?
|
| Urethritis | 1 | 2011 | 2 | 0.350 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 250 | 0.350 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 21 | 0.350 |
Why?
|
| Neisseria meningitidis | 1 | 2011 | 17 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 989 | 0.340 |
Why?
|
| Health Services Needs and Demand | 3 | 2025 | 154 | 0.340 |
Why?
|
| Breast Feeding | 3 | 2018 | 126 | 0.340 |
Why?
|
| Health Personnel | 3 | 2025 | 277 | 0.340 |
Why?
|
| Child Development | 2 | 2025 | 99 | 0.340 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 104 | 0.330 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 89 | 0.330 |
Why?
|
| Hypertension | 3 | 2025 | 835 | 0.330 |
Why?
|
| Prostatic Neoplasms | 3 | 2021 | 1092 | 0.330 |
Why?
|
| Erectile Dysfunction | 1 | 2010 | 39 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 432 | 0.310 |
Why?
|
| Syphilis | 1 | 2009 | 24 | 0.300 |
Why?
|
| Stress, Psychological | 1 | 2016 | 661 | 0.300 |
Why?
|
| Cooperative Behavior | 3 | 2025 | 269 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2021 | 58 | 0.300 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 122 | 0.290 |
Why?
|
| Registries | 2 | 2017 | 437 | 0.290 |
Why?
|
| Appendicitis | 1 | 2008 | 18 | 0.290 |
Why?
|
| Heterosexuality | 1 | 2009 | 97 | 0.290 |
Why?
|
| Databases as Topic | 2 | 2019 | 25 | 0.290 |
Why?
|
| Bibliometrics | 2 | 2025 | 16 | 0.290 |
Why?
|
| Brachytherapy | 2 | 2021 | 11 | 0.290 |
Why?
|
| Drug Prescriptions | 2 | 2025 | 60 | 0.280 |
Why?
|
| Interprofessional Relations | 4 | 2025 | 59 | 0.280 |
Why?
|
| Child Welfare | 3 | 2017 | 49 | 0.270 |
Why?
|
| Quality of Life | 2 | 2024 | 616 | 0.270 |
Why?
|
| Neoplasms | 2 | 2012 | 1377 | 0.260 |
Why?
|
| Liver Neoplasms | 4 | 2014 | 224 | 0.260 |
Why?
|
| Research Personnel | 2 | 2025 | 206 | 0.260 |
Why?
|
| Dentists | 1 | 2006 | 11 | 0.250 |
Why?
|
| Nurses | 1 | 2006 | 55 | 0.240 |
Why?
|
| Education, Veterinary | 1 | 2006 | 3 | 0.240 |
Why?
|
| Child Abuse | 2 | 2017 | 92 | 0.240 |
Why?
|
| Treatment Outcome | 6 | 2025 | 1604 | 0.240 |
Why?
|
| Urban Population | 3 | 2014 | 374 | 0.240 |
Why?
|
| Primary Prevention | 2 | 2017 | 63 | 0.240 |
Why?
|
| Decision Making | 2 | 2019 | 249 | 0.240 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2025 | 3 | 0.240 |
Why?
|
| Risk Assessment | 4 | 2023 | 863 | 0.240 |
Why?
|
| Perioperative Care | 1 | 2025 | 11 | 0.240 |
Why?
|
| Health Status | 4 | 2017 | 442 | 0.240 |
Why?
|
| Authorship | 1 | 2025 | 6 | 0.240 |
Why?
|
| Myocardial Infarction | 3 | 2024 | 247 | 0.240 |
Why?
|
| Regression Analysis | 2 | 2017 | 490 | 0.240 |
Why?
|
| Mass Screening | 3 | 2026 | 541 | 0.230 |
Why?
|
| Pregnancy | 6 | 2025 | 1772 | 0.230 |
Why?
|
| Risk Factors | 9 | 2023 | 3994 | 0.230 |
Why?
|
| Reimbursement Mechanisms | 1 | 2025 | 11 | 0.230 |
Why?
|
| Antihypertensive Agents | 2 | 2025 | 287 | 0.230 |
Why?
|
| Health Priorities | 1 | 2025 | 25 | 0.230 |
Why?
|
| Psychotropic Drugs | 1 | 2025 | 18 | 0.230 |
Why?
|
| Delayed Diagnosis | 1 | 2025 | 38 | 0.230 |
Why?
|
| Stroke | 3 | 2025 | 340 | 0.230 |
Why?
|
| Patient Preference | 1 | 2025 | 60 | 0.230 |
Why?
|
| Occupational Exposure | 2 | 2019 | 91 | 0.230 |
Why?
|
| Telemedicine | 2 | 2022 | 234 | 0.220 |
Why?
|
| Fitness Centers | 1 | 2024 | 4 | 0.220 |
Why?
|
| Public Housing | 2 | 2015 | 16 | 0.220 |
Why?
|
| Wound Healing | 1 | 2025 | 88 | 0.220 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 237 | 0.220 |
Why?
|
| Regional Health Planning | 1 | 2004 | 14 | 0.220 |
Why?
|
| Coronary Angiography | 3 | 2020 | 96 | 0.220 |
Why?
|
| Juvenile Delinquency | 1 | 2004 | 44 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2025 | 497 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2025 | 1067 | 0.210 |
Why?
|
| Health Surveys | 2 | 2009 | 405 | 0.210 |
Why?
|
| Diabetic Angiopathies | 1 | 2023 | 26 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 440 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 76 | 0.200 |
Why?
|
| Postoperative Complications | 1 | 2025 | 263 | 0.200 |
Why?
|
| Nocturia | 1 | 2023 | 3 | 0.200 |
Why?
|
| Public Health | 4 | 2017 | 424 | 0.200 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 140 | 0.200 |
Why?
|
| Internet | 2 | 2017 | 236 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 112 | 0.200 |
Why?
|
| Continuity of Patient Care | 3 | 2026 | 120 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 192 | 0.200 |
Why?
|
| Gender Identity | 1 | 2024 | 117 | 0.200 |
Why?
|
| Occult Blood | 3 | 2012 | 32 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2025 | 502 | 0.200 |
Why?
|
| Educational Status | 2 | 2015 | 339 | 0.190 |
Why?
|
| Nova Scotia | 4 | 2025 | 7 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 455 | 0.190 |
Why?
|
| Prisoners | 1 | 2004 | 102 | 0.190 |
Why?
|
| Social Class | 2 | 2014 | 291 | 0.180 |
Why?
|
| Cardiology | 1 | 2022 | 18 | 0.180 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 278 | 0.180 |
Why?
|
| Health Care Costs | 2 | 2020 | 91 | 0.180 |
Why?
|
| Morphine | 1 | 2022 | 69 | 0.180 |
Why?
|
| Residence Characteristics | 2 | 2015 | 363 | 0.170 |
Why?
|
| Demography | 1 | 2022 | 195 | 0.170 |
Why?
|
| Age Distribution | 5 | 2021 | 249 | 0.170 |
Why?
|
| Health Resources | 1 | 2021 | 37 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2020 | 5 | 0.160 |
Why?
|
| Disease Outbreaks | 3 | 2011 | 175 | 0.160 |
Why?
|
| Atrial Flutter | 1 | 2020 | 7 | 0.160 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 5 | 0.160 |
Why?
|
| Community Health Planning | 1 | 2020 | 38 | 0.160 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2020 | 12 | 0.160 |
Why?
|
| Cholesterol | 3 | 2020 | 232 | 0.160 |
Why?
|
| Lipids | 2 | 2022 | 256 | 0.160 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2019 | 6 | 0.160 |
Why?
|
| Linear Models | 2 | 2018 | 317 | 0.150 |
Why?
|
| Focus Groups | 4 | 2026 | 423 | 0.150 |
Why?
|
| Education, Distance | 1 | 2020 | 46 | 0.150 |
Why?
|
| Occupational Health | 1 | 2019 | 32 | 0.150 |
Why?
|
| Office Visits | 3 | 2021 | 28 | 0.150 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2019 | 2 | 0.150 |
Why?
|
| Colorectal Neoplasms | 3 | 2012 | 512 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 54 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 78 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 12 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 35 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2017 | 359 | 0.150 |
Why?
|
| Pesticides | 1 | 2019 | 62 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 163 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 77 | 0.150 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 2 | 2012 | 7 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2021 | 341 | 0.140 |
Why?
|
| Israel | 1 | 2018 | 21 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.140 |
Why?
|
| Interviews as Topic | 3 | 2025 | 452 | 0.140 |
Why?
|
| Geriatrics | 1 | 2018 | 67 | 0.140 |
Why?
|
| Quality Control | 1 | 2017 | 42 | 0.140 |
Why?
|
| Forecasting | 2 | 2023 | 136 | 0.140 |
Why?
|
| Postnatal Care | 1 | 2017 | 16 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2017 | 48 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 40 | 0.130 |
Why?
|
| Cost of Illness | 1 | 2018 | 98 | 0.130 |
Why?
|
| Needle-Exchange Programs | 1 | 2017 | 12 | 0.130 |
Why?
|
| Immunization | 1 | 2017 | 94 | 0.130 |
Why?
|
| HIV Infections | 2 | 2025 | 2586 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2017 | 21 | 0.130 |
Why?
|
| House Calls | 1 | 2017 | 8 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 173 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 50 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 568 | 0.130 |
Why?
|
| Computers | 1 | 2017 | 35 | 0.130 |
Why?
|
| Family Therapy | 1 | 2017 | 24 | 0.130 |
Why?
|
| Logistic Models | 5 | 2024 | 1009 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 2 | 2014 | 31 | 0.130 |
Why?
|
| Adolescent Health Services | 1 | 2017 | 29 | 0.130 |
Why?
|
| Child Health Services | 1 | 2017 | 42 | 0.130 |
Why?
|
| United States | 6 | 2020 | 5205 | 0.130 |
Why?
|
| Premature Birth | 1 | 2018 | 95 | 0.120 |
Why?
|
| Narration | 1 | 2016 | 37 | 0.120 |
Why?
|
| Whole-Body Irradiation | 2 | 2006 | 9 | 0.120 |
Why?
|
| Stereotaxic Techniques | 2 | 2006 | 20 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2017 | 129 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1081 | 0.120 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 34 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2017 | 187 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2017 | 139 | 0.120 |
Why?
|
| Disease Notification | 1 | 2015 | 5 | 0.120 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2015 | 19 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 760 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 587 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2019 | 469 | 0.110 |
Why?
|
| Mothers | 1 | 2017 | 215 | 0.110 |
Why?
|
| Prognosis | 4 | 2023 | 861 | 0.110 |
Why?
|
| Workload | 2 | 2025 | 25 | 0.110 |
Why?
|
| Organization and Administration | 1 | 2014 | 1 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2014 | 9 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 322 | 0.110 |
Why?
|
| Radiodermatitis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Umbilicus | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 25 | 0.110 |
Why?
|
| Exanthema | 1 | 2014 | 12 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2014 | 54 | 0.100 |
Why?
|
| Time Factors | 4 | 2025 | 1857 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 298 | 0.100 |
Why?
|
| Reoperation | 2 | 2025 | 34 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 235 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2014 | 145 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2024 | 1600 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 287 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 575 | 0.100 |
Why?
|
| Sexual Behavior | 3 | 2016 | 638 | 0.100 |
Why?
|
| Access to Information | 1 | 2012 | 15 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 58 | 0.090 |
Why?
|
| Hotlines | 1 | 2012 | 16 | 0.090 |
Why?
|
| Rural Population | 2 | 2021 | 373 | 0.090 |
Why?
|
| Cholangiocarcinoma | 1 | 2012 | 7 | 0.090 |
Why?
|
| Population Growth | 1 | 2012 | 8 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 758 | 0.090 |
Why?
|
| Meningococcal Infections | 1 | 2011 | 4 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 638 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 96 | 0.090 |
Why?
|
| Algorithms | 1 | 2014 | 509 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 245 | 0.080 |
Why?
|
| Recreation | 1 | 2011 | 43 | 0.080 |
Why?
|
| Smoking | 1 | 2018 | 1024 | 0.080 |
Why?
|
| Organizational Innovation | 2 | 2024 | 21 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2012 | 195 | 0.080 |
Why?
|
| Asia | 2 | 2020 | 98 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2012 | 233 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2006 | 495 | 0.080 |
Why?
|
| Seasons | 1 | 2011 | 139 | 0.080 |
Why?
|
| Professional Autonomy | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nursing Staff | 1 | 2010 | 7 | 0.080 |
Why?
|
| Impotence, Vasculogenic | 1 | 2010 | 13 | 0.080 |
Why?
|
| Carbolines | 1 | 2010 | 17 | 0.080 |
Why?
|
| Nurse's Role | 1 | 2010 | 37 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 25 | 0.080 |
Why?
|
| Purines | 1 | 2010 | 40 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 33 | 0.080 |
Why?
|
| Sulfones | 1 | 2010 | 47 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 163 | 0.080 |
Why?
|
| Survival Rate | 3 | 2018 | 355 | 0.080 |
Why?
|
| Micronesia | 1 | 2009 | 90 | 0.080 |
Why?
|
| Electrocardiography | 2 | 2020 | 185 | 0.080 |
Why?
|
| Contraception, Postcoital | 1 | 2009 | 8 | 0.080 |
Why?
|
| Student Health Services | 1 | 2009 | 12 | 0.080 |
Why?
|
| Imidazoles | 1 | 2010 | 142 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 120 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2006 | 113 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 7 | 0.070 |
Why?
|
| Asthma | 1 | 2013 | 416 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 22 | 0.070 |
Why?
|
| Appendectomy | 1 | 2008 | 17 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1285 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2023 | 760 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 518 | 0.070 |
Why?
|
| Mortality | 2 | 2020 | 175 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2010 | 389 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 719 | 0.060 |
Why?
|
| Dengue | 1 | 2008 | 107 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 437 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2006 | 23 | 0.060 |
Why?
|
| Professional Role | 1 | 2006 | 40 | 0.060 |
Why?
|
| Morbidity | 2 | 2018 | 97 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 49 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2025 | 35 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2025 | 33 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2025 | 153 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2025 | 21 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 70 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2025 | 63 | 0.060 |
Why?
|
| Aging | 2 | 2020 | 783 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 374 | 0.060 |
Why?
|
| Triglycerides | 1 | 2005 | 147 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 18 | 0.050 |
Why?
|
| Organizational Case Studies | 1 | 2024 | 31 | 0.050 |
Why?
|
| Public Opinion | 1 | 2024 | 20 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2005 | 123 | 0.050 |
Why?
|
| Social Perception | 1 | 2005 | 72 | 0.050 |
Why?
|
| Pacific Islands | 1 | 2004 | 123 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 15 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2004 | 28 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 140 | 0.050 |
Why?
|
| Censuses | 1 | 2004 | 28 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 24 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 32 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 147 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 51 | 0.050 |
Why?
|
| Agglutination Tests | 1 | 2003 | 4 | 0.050 |
Why?
|
| Communication | 1 | 2025 | 210 | 0.050 |
Why?
|
| Serotyping | 1 | 2003 | 37 | 0.050 |
Why?
|
| Thiazides | 1 | 2023 | 3 | 0.050 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2023 | 7 | 0.050 |
Why?
|
| Information Dissemination | 2 | 2015 | 66 | 0.050 |
Why?
|
| Women's Health | 1 | 2004 | 160 | 0.050 |
Why?
|
| Diuretics | 1 | 2023 | 51 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 33 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2003 | 45 | 0.050 |
Why?
|
| Physician-Nurse Relations | 1 | 2002 | 3 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 284 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 238 | 0.050 |
Why?
|
| Age Factors | 2 | 2017 | 1154 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2022 | 35 | 0.050 |
Why?
|
| Cities | 1 | 2022 | 79 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 195 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 110 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 165 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2021 | 27 | 0.040 |
Why?
|
| Prescription Drugs | 1 | 2021 | 32 | 0.040 |
Why?
|
| Health Behavior | 1 | 2005 | 575 | 0.040 |
Why?
|
| Risk Management | 1 | 2020 | 8 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 55 | 0.040 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 158 | 0.040 |
Why?
|
| Risk-Taking | 2 | 2017 | 457 | 0.040 |
Why?
|
| Students | 1 | 2005 | 626 | 0.040 |
Why?
|
| Group Processes | 1 | 2018 | 23 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2018 | 50 | 0.030 |
Why?
|
| Needle Sharing | 1 | 2017 | 11 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2017 | 74 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 74 | 0.030 |
Why?
|
| Early Detection of Cancer | 2 | 2012 | 449 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 35 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2017 | 74 | 0.030 |
Why?
|
| Depression | 1 | 2024 | 863 | 0.030 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 148 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2016 | 33 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2024 | 830 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2018 | 193 | 0.030 |
Why?
|
| Capitation Fee | 1 | 2016 | 3 | 0.030 |
Why?
|
| Quebec | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fee-for-Service Plans | 1 | 2016 | 21 | 0.030 |
Why?
|
| Professional Competence | 1 | 2015 | 42 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2016 | 44 | 0.030 |
Why?
|
| School Health Services | 1 | 2016 | 90 | 0.030 |
Why?
|
| Attitude | 1 | 2015 | 108 | 0.030 |
Why?
|
| Hospitals, Rural | 1 | 2014 | 25 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 42 | 0.030 |
Why?
|
| Schools | 1 | 2016 | 283 | 0.030 |
Why?
|
| Models, Economic | 1 | 2013 | 28 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 75 | 0.030 |
Why?
|
| Bronchitis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 179 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 4 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 2012 | 5 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 132 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 1723 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 375 | 0.020 |
Why?
|
| Delegation, Professional | 1 | 2010 | 1 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2010 | 11 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2010 | 17 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2009 | 7 | 0.020 |
Why?
|
| Pregnancy, Unplanned | 1 | 2009 | 29 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 86 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 56 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2008 | 3 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 98 | 0.020 |
Why?
|
| Animals | 1 | 2006 | 16992 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 139 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 86 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 117 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2009 | 187 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.020 |
Why?
|
| Unsafe Sex | 1 | 2009 | 162 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 458 | 0.020 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2006 | 1 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 8 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 39 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2006 | 84 | 0.010 |
Why?
|
| Universities | 1 | 2009 | 559 | 0.010 |
Why?
|
| Fasting | 1 | 2005 | 56 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 73 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 99 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 154 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 245 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 224 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2002 | 122 | 0.010 |
Why?
|
| Health Education | 1 | 2005 | 363 | 0.010 |
Why?
|
| Mammography | 1 | 2002 | 212 | 0.010 |
Why?
|